Dynasty Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Dynasty Wealth Management's IONS Position: Q3 2026 in Review
Dynasty Wealth Management increased its Ionis Pharmaceuticals (IONS) stake by 3.7% in Q3 2026, buying an estimated $28.5K and bringing the position to 14,162 shares worth $632K. The position accounts for ﹤0.01% of the portfolio, ranked #216.
Dynasty Wealth Management first reported a position in IONS in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.11M in Q4 2025. 458 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Dynasty Wealth Management held 14,162 shares of Ionis Pharmaceuticals worth $632K as of Q3 2026.
- Dynasty Wealth Management bought 501 Ionis Pharmaceuticals shares in Q3 2026, an estimated $28.5K.
- Ionis Pharmaceuticals made up ﹤0.01% of Dynasty Wealth Management's portfolio in Q3 2026, its #216 holding.
- Dynasty Wealth Management first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Dynasty Wealth Management's Ionis Pharmaceuticals position peaked at $1.11M in Q4 2025.
- 458 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Dynasty Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.